Industry-defined opportunities for advancing big data capabilities in biopharmaceutical manufacturing.

Hart R, Kedia S, Lanspa R, Lichtner S, Lee KH

Open source

DOI
10.3389/fbioe.2026.1886721
Published
2026
Container
Frontiers in bioengineering and biotechnology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fbioe.2026.1886721,
  title = {Industry-defined opportunities for advancing big data capabilities in biopharmaceutical manufacturing.},
  author = {Hart R and Kedia S and Lanspa R and Lichtner S and Lee KH},
  year = {2026},
  journal = {Frontiers in bioengineering and biotechnology},
  doi = {10.3389/fbioe.2026.1886721},
  url = {https://doi.org/10.3389/fbioe.2026.1886721}
}

RIS

TY  - JOUR
TI  - Industry-defined opportunities for advancing big data capabilities in biopharmaceutical manufacturing.
AU  - Hart R
AU  - Kedia S
AU  - Lanspa R
AU  - Lichtner S
AU  - Lee KH
PY  - 2026
JO  - Frontiers in bioengineering and biotechnology
DO  - 10.3389/fbioe.2026.1886721
UR  - https://doi.org/10.3389/fbioe.2026.1886721
ER  - 

APA

R, H., S, K., R, L., S, L., & KH, L. (2026). Industry-defined opportunities for advancing big data capabilities in biopharmaceutical manufacturing.. Frontiers in bioengineering and biotechnology. https://doi.org/10.3389/fbioe.2026.1886721

Source records